Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study; response to comments.

Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW.

J Cyst Fibros. 2017 Nov;16(6):e21. doi: 10.1016/j.jcf.2017.09.008. Epub 2017 Oct 25. No abstract available.

PMID:
29079141
2.

Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.

Barr HL, Cámara M, Barrett D, Williams P, Forrester D, Smyth A, Honeybourne D, Whitehouse J, Nash E, Dewar J, Knox A, Fogarty AW.

ERJ Open Res. 2017 Aug 25;3(3). pii: 00057-2017. doi: 10.1183/23120541.00057-2017. eCollection 2017 Jul.

3.

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.

Barr HL, Halliday N, Barrett DA, Williams P, Forrester DL, Peckham D, Williams K, Smyth AR, Honeybourne D, L Whitehouse J, Nash EF, Dewar J, Clayton A, Knox AJ, Cámara M, Fogarty AW.

J Cyst Fibros. 2017 Mar;16(2):230-238. doi: 10.1016/j.jcf.2016.10.005. Epub 2016 Oct 20.

4.

Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial.

Forrester DL, Knox AJ, Smyth AR, Barr HL, Simms R, Pacey SJ, Pavord ID, Honeybourne D, Dewar J, Clayton A, Fogarty AW.

Pediatr Pulmonol. 2016 Mar;51(3):253-7. doi: 10.1002/ppul.23370. Epub 2015 Dec 27.

PMID:
26709241
5.

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis.

Barr HL, Halliday N, Cámara M, Barrett DA, Williams P, Forrester DL, Simms R, Smyth AR, Honeybourne D, Whitehouse JL, Nash EF, Dewar J, Clayton A, Knox AJ, Fogarty AW.

Eur Respir J. 2015 Oct;46(4):1046-54. doi: 10.1183/09031936.00225214. Epub 2015 May 28.

6.

Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study.

Bradley JM, Blume SW, Balp MM, Honeybourne D, Elborn JS.

Eur Respir J. 2013 Mar;41(3):571-7. doi: 10.1183/09031936.00224911. Epub 2012 Jul 26.

7.

Cystic fibrosis papers of the year 2010-2011.

Honeybourne D.

J R Soc Med. 2012 Jun;105 Suppl 2:S30-5. doi: 10.1258/jrsm.2012.12s006. Review. No abstract available.

8.

Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis.

Mutagi A, Nash EF, Cameron S, Abbott G, Agostini P, Whitehouse JL, Honeybourne D, Boxall E.

J Hosp Infect. 2012 Jun;81(2):104-8. doi: 10.1016/j.jhin.2012.03.004. Epub 2012 May 10.

PMID:
22579442
9.

Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis.

Dowman JK, Watson D, Loganathan S, Gunson BK, Hodson J, Mirza DF, Clarke J, Lloyd C, Honeybourne D, Whitehouse JL, Nash EF, Kelly D, van Mourik I, Newsome PN.

Am J Transplant. 2012 Apr;12(4):954-64. doi: 10.1111/j.1600-6143.2011.03904.x. Epub 2012 Jan 6.

10.

Intussusception in adults with cystic fibrosis: a case series with review of the literature.

Nash EF, Stephenson A, Helm EJ, Ho T, Thippanna CM, Ali A, Whitehouse JL, Honeybourne D, Tullis E, Durie PR.

Dig Dis Sci. 2011 Dec;56(12):3695-700. doi: 10.1007/s10620-011-1790-z. Epub 2011 Jun 16. No abstract available.

PMID:
21678050
11.

"Cepacia syndrome" associated with Burkholderia cepacia (Genomovar I) infection in an adolescent with cystic fibrosis.

Nash EF, Thomas A, Whitmill R, Rashid R, Barker B, Rayner RJ, Whitehouse JL, Honeybourne D.

Pediatr Pulmonol. 2011 May;46(5):512-4. doi: 10.1002/ppul.21404. Epub 2010 Dec 30. No abstract available.

PMID:
21194170
12.

Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis.

Nash EF, Whitmill R, Barker B, Rashid R, Whitehouse JL, Honeybourne D.

Thorax. 2011 Mar;66(3):259. doi: 10.1136/thx.2010.140822. Epub 2010 Sep 6. No abstract available.

PMID:
20820065
13.

Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis.

Zhang L, Gough J, Christmas D, Mattey DL, Richards SC, Main J, Enlander D, Honeybourne D, Ayres JG, Nutt DJ, Kerr JR.

J Clin Pathol. 2010 Feb;63(2):156-64. doi: 10.1136/jcp.2009.072561. Epub 2009 Dec 2.

14.

Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples.

Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG.

J Clin Microbiol. 2009 Nov;47(11):3444-8. doi: 10.1128/JCM.00459-09. Epub 2009 Aug 26.

15.

Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa.

Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG.

J Clin Microbiol. 2008 Oct;46(10):3491-3. doi: 10.1128/JCM.00357-08. Epub 2008 Aug 6.

16.

Renal impairment in cystic fibrosis.

Mukherjee R, Whitehouse J, Honeybourne D.

Thorax. 2008 May;63(5):473. doi: 10.1136/thx.2007.087098. No abstract available.

PMID:
18443168
17.

Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.

Andrews J, Honeybourne D, Ashby J, Jevons G, Fraise A, Fry P, Warrington S, Hawser S, Wise R.

J Antimicrob Chemother. 2007 Sep;60(3):677-80. Epub 2007 Jul 10.

PMID:
17623694
18.

Environmental Burkholderia cepacia complex isolates in human infections.

Baldwin A, Mahenthiralingam E, Drevinek P, Vandamme P, Govan JR, Waine DJ, LiPuma JJ, Chiarini L, Dalmastri C, Henry DA, Speert DP, Honeybourne D, Maiden MC, Dowson CG.

Emerg Infect Dis. 2007 Mar;13(3):458-61.

19.

Reliability of multilocus sequence typing of the Burkholderia cepacia complex in cystic fibrosis.

Waine DJ, Henry DA, Baldwin A, Speert DP, Honeybourne D, Mahenthiralingam E, Dowson CG.

J Cyst Fibros. 2007 May;6(3):215-9. Epub 2006 Dec 1.

20.

Cross-infection in cystic fibrosis: the knowledge and behaviour of adult patients.

Waine DJ, Whitehouse J, Honeybourne D.

J Cyst Fibros. 2007 Jul;6(4):262-6. Epub 2006 Dec 1.

21.

The role of quinolones in chronic obstructive pulmonary disease.

Banerjee D, Honeybourne D.

Curr Opin Infect Dis. 1999 Dec;12(6):543-7.

PMID:
17035819
22.

Effect of a multidisciplinary lung investigation day on a rapid access lung cancer service.

Rajasekaran AB, Silvey D, Leung B, Honeybourne D, Cayton RM, Reynolds J, Trotter S, Roland MA.

Postgrad Med J. 2006 Jun;82(968):414-6. No abstract available.

23.

Commercial mushrooms and bean sprouts are a source of Pseudomonas aeruginosa.

Curran B, Morgan JA, Honeybourne D, Dowson CG.

J Clin Microbiol. 2005 Nov;43(11):5830-1. No abstract available.

24.

Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis.

Chambers D, Scott F, Bangur R, Davies R, Lim A, Walters S, Smith G, Pitt T, Stableforth D, Honeybourne D.

Eur Respir J. 2005 Oct;26(4):651-6.

25.

Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, Speert DP, Lipuma JJ, Vandamme P, Dowson CG.

J Clin Microbiol. 2005 Sep;43(9):4665-73.

26.

The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD.

Banerjee D, Khair OA, Honeybourne D.

Respir Med. 2005 Feb;99(2):208-15.

27.

Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD.

Banerjee D, Khair OA, Honeybourne D.

Eur Respir J. 2004 May;23(5):685-91.

28.
29.

Community-acquired pneumonia mortality: a potential link to antibiotic prescribing trends in general practice.

Price DB, Honeybourne D, Little P, Mayon-White RT, Read RC, Thomas M, Wale MC, FitzGerald P, Weston AR, Winchester CC.

Respir Med. 2004 Jan;98(1):17-24.

30.

Bilateral fractured neck of the femur in an adult patient with cystic fibrosis.

Lim AY, Isopescu S, Thickett KM, Gumery LB, Darby AJ, Honeybourne D, Stableforth DE.

Eur J Intern Med. 2003 May;14(3):196-198.

PMID:
12798220
31.

Intrapulmonary penetration of linezolid.

Honeybourne D, Tobin C, Jevons G, Andrews J, Wise R.

J Antimicrob Chemother. 2003 Jun;51(6):1431-4. Epub 2003 May 13. Erratum in: J Antimicrob Chemother. 2003 Sep;52(3):536.

PMID:
12746375
32.

Exhaled nitric oxide in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.

Lim AY, Chambers DC, Ayres JG, Stableforth DE, Honeybourne D.

Respir Med. 2003 Apr;97(4):331-6.

33.

Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.

Andrews J, Honeybourne D, Jevons G, Boyce M, Wise R, Bello A, Gajjar D.

J Antimicrob Chemother. 2003 Mar;51(3):727-30.

PMID:
12615879
34.

Survey of flexible fibreoptic bronchoscopy in the UK.

Honeybourne D.

Eur Respir J. 2002 Sep;20(3):789. No abstract available.

35.

Community-acquired pneumonia in ambulatory patients: relative importance of atypical pathogens.

Honeybourne D.

Int J Antimicrob Agents. 2001;18 Suppl 1:S57-61. Review.

PMID:
11574197
36.
37.

Lung concentrations of telithromycin after oral dosing.

Khair OA, Andrews JM, Honeybourne D, Jevons G, Vacheron F, Wise R.

J Antimicrob Chemother. 2001 Jun;47(6):837-40.

PMID:
11389116
38.

Extrapleural bronchial artery ligation for life-threatening hemoptysis in cystic fibrosis--a case report.

Kaukuntla HK, Amer KM, Honeybourne D, Stableforth DE, Khalil-Marzouk JF.

Angiology. 2000 Sep;51(9):787-92.

PMID:
10999621
41.

Pleural effusion and fever in a middle-aged Asian man.

Woolhouse I, Collinson H, Honeybourne D, Ferner RE.

Postgrad Med J. 1999 Nov;75(889):687-8. No abstract available.

42.

Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.

Soman A, Honeybourne D, Andrews J, Jevons G, Wise R.

J Antimicrob Chemother. 1999 Dec;44(6):835-8.

PMID:
10590288
43.

A study to investigate the ability of subjects with chronic lung diseases to activate the roadside Lion Alcolmeter SL-400.

Honeybourne D, Moore AJ, Butterfield K, Azzan L.

Med Sci Law. 1999 Oct;39(4):337-41.

PMID:
10581914
44.

Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract.

Wise R, Honeybourne D.

Eur Respir J. 1999 Jul;14(1):221-9. Review. Erratum in: Eur Respir J 1999 Nov;14(5):1239.

45.

Chlamydia pneumoniae infection and ethnic origin.

Cook PJ, Davies P, Wise R, Honeybourne D.

Ethn Health. 1998 Nov;3(4):237-46.

PMID:
10403105
47.

Chlamydia pneumoniae and asthma.

Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R.

Thorax. 1998 Apr;53(4):254-9.

49.
50.

Chlamydia pneumoniae antibodies in severe essential hypertension.

Cook PJ, Lip GY, Davies P, Beevers DG, Wise R, Honeybourne D.

Hypertension. 1998 Feb;31(2):589-94.

PMID:
9461226

Supplemental Content

Loading ...
Support Center